Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Interest Expenses: 2014-2024

Historic Interest Expenses for Collegium Pharmaceutical (COLL) over the last 10 years, with Dec 2024 value amounting to $74.0 million.

  • Collegium Pharmaceutical's Interest Expenses rose 18.34% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.7 million, marking a year-over-year increase of 21.35%. This contributed to the annual value of $74.0 million for FY2024, which is 11.24% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Interest Expenses stood at $74.0 million for FY2024, which was down 11.24% from $83.3 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Interest Expenses registered a high of $83.3 million during FY2023, and its lowest value of $21.0 million during FY2021.
  • Moreover, its 3-year median value for Interest Expenses was $74.0 million (2024), whereas its average is $73.5 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Interest Expenses soared by 3,077.34% in 2020, and later decreased by 27.24% in 2021.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Interest Expenses stood at $28.9 million in 2020, then dropped by 27.24% to $21.0 million in 2021, then skyrocketed by 200.81% to $63.2 million in 2022, then soared by 31.84% to $83.3 million in 2023, then fell by 11.24% to $74.0 million in 2024.